TNF inhibitor
Date |
Type | Title | Save |
|---|---|---|---|
| 28 Dec 2019 | Social | Is the Serious infection (SIE) risk different between TCZ and TNFi? Not when used after failing 1 TNFi; But for biologic initiators, SIE risk was higher in TCZ compared to TNFi or ABA (based on claims data from 16074 TCZ matched to 33109 TNFi initiators https://t.co/ZHVWF9fIHF | |
| 27 Dec 2019 | News | Best of 2019 - The Shame Behind Adalimumab Biosimilars | |
| 09 Dec 2019 | Slide of the day | Even More Biosimilars | |
| 02 Dec 2019 | Social | Metanalysis shows that although MTX may blunt some vaccine responses (eg Pneumococcal), the use of MTX, TNF inhibitors and other biologics should not deter vaccination as most vaccine responses are preserved despite therapy. https://t.co/KINrQMIQkt | |
| 25 Nov 2019 | Social | VERVE results - Live zoster vaccine safe and effective in >600 patients with autoimmune diseases treated wth TNFi abstr#0824 #ACR19 @CCalabreseDO https://t.co/F8ipuG08O3 | |
| 13 Nov 2019 | Social | RT @hausmannMD: Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #AC… | |
| 13 Nov 2019 | Social | RT @Janetbirdope: Infections In out patients are increased as measured by antimicromial scripts with RA and TNFi use comparing popn control… | |
| 13 Nov 2019 | Social | RT @DrKanikaMonga: - Risk of bDMARD withdrawal higher for TNFi monotherapy compared w/ cs/bDMARD combination - If monotherapy necessary, et… | |
| 10 Nov 2019 | ACR Video | Use of TNF Inhibitors: Dr. Olga Petryna | |
| 30 Oct 2019 | News | Psoriasis Risk Increased with TNF Inhibitors in Juveniles | |
| 28 Oct 2019 | News | The Shame Behind Adalimumab Biosimilars | |
| 28 Oct 2019 | Slide of the day | New Biosimilars for Rheumatology - 2019 | |
| 22 Oct 2019 | News | Pain Persists Despite TNF Inhibitor Use | |
| 22 Oct 2019 | News | Adalimumab and Pregnancy Outcomes | |
| 12 Aug 2019 | News | Enbrel Patent Battle Won by Amgen | |
| 01 Aug 2019 | News | TNF Inhibitor and Biologic Induced Psoriasis | |
| 24 Jul 2019 | Slide of the day | anti-TNF Biosimilars in USA | |
| 09 May 2019 | Social | Analysis of claims data compared hospitalized infection rates among 11,248 matched pairs of new initiators of abatacept or TNF inhibitors. Serious hosp infections were significantly lower in ABA vs infliximab (HR 0.63; 0.47-0.85), but similar to ETN & ADA https://t.co/JhXlC7p1A7 | |
| 29 Mar 2019 | News | FDA Approves Cimzia for Non-Radiographic Axial Spondyloarthritis | |
| 13 Mar 2019 | News | Lower TNF Inhibitor Persistence in Spondylitis |
